Sangamo Therapeutics, Inc. (SGMO) Social Stream



Sangamo Therapeutics, Inc. (SGMO): $8.75

-0.13 (-1.46%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add SGMO to Watchlist
Sign Up

Industry: Biotech


Ranked

of 504

in industry

Sangamo Therapeutics Inc (SGMO) Price Targets From Analysts

Use the tables below to see what analysts covering Sangamo Therapeutics Inc think about its future price and what recommendations they have for investors and traders.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
9 $30 $11 $20.67 $8.88 132.77%

The Trend in the Analyst Price Target


Over the past 72 days, SGMO's average price target has gone down $0.22.

SGMO reports an average of 80.18% for its upside potential over the past 16 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-09-20 9 30 11 20.67 9.280 122.74%
2021-09-19 9 30 11 20.67 9.550 116.44%
2021-09-18 9 30 11 20.67 9.550 116.44%
2021-09-11 9 30 11 20.67 9.660 113.98%
2021-09-04 9 30 11 20.67 10.080 105.06%
2021-08-28 9 30 11 20.67 9.990 106.91%
2021-08-14 9 30 11 20.67 10.050 105.67%
2021-08-07 9 30 11 20.67 9.760 111.78%
2021-08-05 9 30 11 20.89 9.970 109.53%
2021-08-01 9 30 11 20.89 9.580 118.06%
2021-07-24 9 30 11 20.89 9.940 110.16%
2021-07-17 9 30 11 20.89 9.820 112.73%
2021-07-10 9 30 11 20.89 10.640 96.33%
2021-07-03 9 30 11 20.89 11.710 78.39%
2021-06-26 9 30 11 20.89 12.020 73.79%
2021-06-13 10 30 11 20.10 11.760 70.92%
2021-06-05 10 30 11 20.10 10.890 84.57%
2021-05-22 10 30 11 20.10 10.820 85.77%
2021-05-15 10 30 11 20.10 10.850 85.25%
2021-05-08 11 30 11 19.73 10.540 87.19%
2021-04-25 10 30 11 19.80 11.710 69.09%
2021-04-17 10 30 11 19.80 11.480 72.47%
2021-04-10 10 30 11 19.80 11.020 79.67%
2021-04-03 10 30 11 19.80 12.280 61.24%
2021-03-20 10 30 11 19.80 13.230 49.66%
2021-03-13 10 30 12 19.90 11.540 72.44%
2021-03-06 10 30 12 19.90 11.360 75.18%
2021-02-27 10 36 12 20.60 11.490 79.29%
2021-02-20 10 36 12 20.70 13.210 56.7%
2021-02-13 10 36 12 20.70 13.680 51.32%
2021-02-06 10 36 12 20.70 14.640 41.39%
2021-01-30 10 36 12 20.70 13.660 51.54%
2021-01-23 10 36 12 20.70 14.950 38.46%
2021-01-16 10 36 12 20.70 15.750 31.43%
2021-01-09 10 36 12 20.70 16.980 21.91%
2021-01-02 8 36 12 21.88 15.605 40.21%
2020-12-26 8 36 12 21.88 17.810 22.85%
2020-12-19 8 36 12 21.88 14.320 52.79%
2020-12-09 8 36 12 20.50 10.230 100.39%
2020-12-07 8 36 12 20.50 9.280 120.91%
2020-11-14 7 36 12 21.43 11.480 86.67%
2020-10-07 8 36 11 20.25 NA NA%
2020-09-19 8 36 11 20.12 NA NA%
2020-09-02 7 36 11 20.14 NA NA%
2020-08-23 7 36 11 20.14 NA NA%
2020-08-06 7 36 11 20.14 NA NA%
2020-07-06 6 36 11 21.50 NA NA%
2020-06-30 5 36 11 21.40 NA NA%
2020-06-19 5 36 11 21.40 NA NA%
2020-06-09 5 36 11 21.80 NA NA%
2020-06-07 5 36 10 21.60 NA NA%

SGMO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.55 2 6 3 0 0 11

The Trend in the Broker Recommendations


SGMO's average broker recommendation rating worsened by 0.52 over the prior 16 months.

The bullet points below may help you gain a better understanding of what the metrics in the price target and recommendations tables above mean for SGMO as an investment opportunity.

  • SGMO has a lower variance in analysts' estimates than 6.34999999999999% of all US stocks.
  • SGMO has a greater upside potential (average analyst target price relative to current price) than 84.83% of all US stocks.
  • SGMO has a greater number of analysts covering the stock than 82.07% of Pharmaceutical Products stocks.
  • SGMO has a higher average analyst price target than 25.39% of stocks in the mid market cap category.

In the Pharmaceutical Products industry, DRNA, RPTX and STOK are the three stocks most similar to Sangamo Therapeutics Inc regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding SGMO using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 2.8183 seconds.